// App-Quantinova.ai

453 : Multi-Genomics of Relapsed B-Cell Precursor Acute Lymphoblastic Leukemia Reveals Three Distinct Genetic Clusters Characterized By Different Alterations

Researchers

Presenter

  • Michael P Schroeder

Principal Investigators

  • Cornelia Eckert

  • Dieter Hoelzer

  • Heike Pfeiffer

  • Michael A Rieger

  • Stefanie Gollner

  • Thomas Oellerich

  • Diego Yepes

  • Renate Kirschner-Schwabe

  • Monika Bruggemann

  • Carsten Muller-Tidow

  • Hubert Serve

  • Lorenz Bastian

  • Claudia D. Baldus

  • Alva Rani James

  • Nicola Gokbuget

  • Cornelia Schlee

  • Jutta Ortiz Tanchez

  • Konstandina Isaakidis

  • Stefan Schwartz

  • Thomas Burmeister

Medical Centers

  • German Cancer Consortium (DKTK), Heidelberg, Germany

  • Department of Hematology and Oncology, Campus Benjamin Franklin, Charite University Hospital, Berlin, Germany

  • Department of Pediatric Oncology/Hematology, Campus Rudolf Virchow, Charite University Hospital, Berlin, Germany

  • Dept. of Medicine II, Hematology/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt/Main, Germany

  • German Cancer Research Centre, Heidelberg, Germany

  • Department of Medicine, Hematology/Oncology, Goethe University of Frankfurt, Frankfurt, Germany

  • Department Hematology, Oncology and Tumor Immunology, Charite University Hospital, Berlin, Germany

  • Goethe University, Frankfurt, Germany

  • Department of Medicine, Hematology/Oncology, Goethe University of Frankfurt, Frankfurt, Germany

  • University Hospital Frankfurt, Goethe University, Frankfurt, Germany

  • Department of General Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany

  • Department of Hematology and Oncology, University of Halle, Halle, Germany

  • German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim